| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |